Biochem/physiol Actions
HS-276 is an orally active, potent and selective TGF-β-activated kinase-1 (TAK-1; TAK1) inhibitor (Ki = 2.5 nM; IC50 = 8.25 nM) that significantly reduced cytokines production in THP-1 human macrophages upon LPS/IFNγ treatment (IC50 = 138 nM/TNF, 201 nM/IL-6, and 234 nM/IL-1β). HS-276 effectively attenuates arthritic-like symptoms in the CIA mouse rheumatoid arthritis (RA) model (10-30 mg/kg/d p.o. or 25 mg/kg/d i.p.).
- UPC:
- 41113404
- Condition:
- New
- HazmatClass:
- No
- MPN:
- SML3629-25MG
- CAS:
- 2767422-72-8
akash.verma@cenmed.com
(732) 447-1115





